Dr Santu Saha
Rachel Howarth
Dr Sweta Sharma Saha
Dr Charles Kelly
| Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer | 2023 |
|
Dr Santu Saha
Dr Stuart Rundle
Dr Ioannis Kotsopoulos
Dr Jake Begbie
Rachel Howarth
et al. | Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy | 2022 |
|
Dr Praveen Dhondurao Sudhindar
Daniel Wainwright
Dr Santu Saha
Rachel Howarth
Misti McCain
et al. | HCV Activates Somatic L1 Retrotransposition—A Potential Hepatocarcinogenesis Pathway | 2021 |
|
Dr Jack Leslie
Benjamin Millar
Alicia Del Carpio Pons
Rachel Burgoyne
Joseph Frost
et al. | FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis | 2020 |
|
Dr Sally Spendiff
Rachel Howarth
Dr Grace McMacken
Tracey Davey
Dr Andreas Roos
et al. | Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome | 2020 |
|
Dr Santu Saha
Rachel Howarth
Dr Isabel Pappworth
Professor Kevin Marchbank
Professor Nicola Curtin
et al. | Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment. | 2020 |
|
Dr Grace McMacken
Dr Sally Spendiff
Professor Roger Whittaker
Emily O'Connor
Rachel Howarth
et al. | Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome | 2019 |
|
Dr Eva Moran Salvador
Dr Pier Paoli
Dr Graham Smith
Dr Agata Page
Rachel Howarth
et al. | MeCP2 exerts global control over the myofibroblast transcriptome and reveals new regulators of fibrosis | 2015 |
|
Dr Luigi Locatelli
Dr Pier Paoli
Dr Timothy Hardy
Rachel Howarth
Professor Fiona Oakley
et al. | Sequence Profiling of miRNAs Reveals mir-150-5p as a Regulator of Transdifferentiation | 2015 |
|
